Skip to main content
Figure 1 | BMC Endocrine Disorders

Figure 1

From: Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes

Figure 1

Insulin and glucose profiles. Serum insulin concentration (a) and plasma glucose concentration (b) during 9-hour treatment with insulin aspart (open circles), BIAsp70 (black rectangles), BIAsp50 (open rectangles) and human insulin (black circles). The arrow indicates human insulin injection time, and the vertical dotted line indicates the time of meal. Serum insulin and plasma glucose profiles are illustrated as mean levels (reprinted with permission from Diabetes Technology & Therapeutics).

Back to article page